Stephen Safe

发表

Editorial overview: Mechanistic toxicology

Martin van den Berg, Stephen Safe, 2019 .

Toxic equivalency factors for dioxin-like PCBs

Linda S. Birnbaum, Annika Hanberg, E. Yrjänheikki, 1994 .

Hazard andRisk Assessment ofChemical Mixtures Using theToxic Equivalency Factor Approach

Stephen Safe, S. Safe, 1998 .

Nanotechnology systems for drug delivery, multi-modal targeting and imaging of tumors

Ning Zhang, Stephen Safe, Kevin P. Francis, 2012 .

Polychlorinated Biphenyls (PCBs): Mammalian and Environmental Toxicology

Stephen Safe, Robert L. Dedrick, S. Safe, 1987 .

Which is the Real Obesogen? The Pizza or the Pizza Box?

Stephen Safe, 2017 .

The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells.

Stephen Safe, S. Safe, S. Mertens-Talcott, 2007, Cancer research.

Endocrine disruptors and human health: is there a problem.

Stephen Safe, S. Safe, 2004, Toxicology.

Egr‐1 is activated by 17β‐estradiol in MCF‐7 cells by mitogen‐activated protein kinase‐dependent phosphorylation of ELK‐1

Chien-Cheng Chen, Stephen Safe, S. Safe, 2004, Journal of cellular biochemistry.

Polyhalogenated aromatics: uptake, disposition and metabolism

Stephen Safe, S. Safe, 1989 .

Regulation of KiSS-1 Metastasis Suppressor Gene Expression in Breast Cancer Cells by Direct Interaction of Transcription Factors Activator Protein-2α and Specificity Protein-1*

Stephen Safe, S. Safe, M. Abdelrahim, 2006, Journal of Biological Chemistry.

NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration

Stephen Safe, S. Safe, Mandip Singh, 2016, Molecular and Cellular Biology.

Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.

Brad Saville, Stephen Safe, S. Safe, 2003, Molecular endocrinology.

Interaction of Methoxychlor and Related Compounds with Estrogen Receptor α and β, and Androgen Receptor: Structure-Activity Studies

Donald P. McDonnell, Kevin W. Gaido, Susan C. Maness, 2000 .

Multiphoton spectral analysis of benzo[a]pyrene uptake and metabolism in a rat liver cell line.

Bruce D Hammock, Rola Barhoumi, Stephen Safe, 2011, Toxicology and applied pharmacology.

The origin, fate, and health effects of combustion by-products: a research framework.

Günter Oberdörster, Heidelore Fiedler, William A Suk, 2002, Environmental health perspectives.

Domains of Estrogen Receptor α (ERα) Required for ERα/Sp1-Mediated Activation of GC-Rich Promoters by Estrogens and Antiestrogens in Breast Cancer Cells

Brad Saville, Stephen Safe, S. Safe, 2003 .

Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors

Stephen Safe, S. Safe, Satya S. Pathi, 2013, International journal of cancer.

Natural Products as Mechanism‐based Anticancer Agents: Sp Transcription Factors as Targets

Stephen Safe, S. Safe, Ravi Kasiappan, 2016, Phytotherapy research : PTR.

Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways.

Stephen Safe, S. Safe, Kyounghyun Kim, 2008, Journal of molecular endocrinology.

Cooperative Coactivation of Estrogen Receptor α in ZR-75 Human Breast Cancer Cells by SNURF and TATA-binding Protein*

Stephen Safe, Ismael Samudio, S. Safe, 2002, The Journal of Biological Chemistry.

Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells.

Stephen Safe, S. Safe, M. Abdelrahim, 2003, Molecular pharmacology.

Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α and SP proteins

Brad Saville, Stephen Safe, Ismael Samudio, 2004, Oncogene.

The Aryl Hydrocarbon Receptor Mediates Degradation of Estrogen Receptor α through Activation of Proteasomes

Stephen Safe, S. Safe, M. Abdelrahim, 2003, Molecular and Cellular Biology.

Ligand-, Cell-, and Estrogen Receptor Subtype (α/β)-dependent Activation at GC-rich (Sp1) Promoter Elements*

Eva Enmark, Brad Saville, Stephen Safe, 2000, The Journal of Biological Chemistry.

Role of specificity protein transcription factors in estrogen-induced gene expression in MCF-7 breast cancer cells.

Qian Wu, Stephen Safe, S. Safe, 2007, Journal of molecular endocrinology.

Comparative aryl hydrocarbon hydroxylase induction activities of commercial PCBs in Wistar rats and rat hepatoma H-4-II E cells in culture

Stephen Safe, S. Safe, T. Sawyer, 1984 .

Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer.

Rola Barhoumi, Stephen Safe, S. Safe, 2005, Molecular endocrinology.

Estrogen‐dependent regulation of ornithine decarboxylase in breast cancer cells through activation of nongenomic cAMP‐dependent pathways

Stephen Safe, Ismael Samudio, S. Safe, 2004, Molecular carcinogenesis.

IDENTIFICATION OF ONCOGENIC MicroRNA-17-92/ZBTB4/SPECIFICITY PROTEIN AXIS IN BREAST CANCER

Stephen Safe, P. Defossez, Ju-Seog Lee, 2011, Oncogene.

Polychlorinated dibenzofurans; quantitative structure activity relationships

G. Mason, Stephen Safe, M. Romkes, 1985 .

The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice.

Richard E. Peterson, Stephen Safe, Robert W. Moore, 2009, Biochemical pharmacology.

Transcriptional activation of cathepsin D gene expression by 17β-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition

Stephen Safe, Ismael Samudio, S. Safe, 2001, Molecular and Cellular Endocrinology.

Resveratrol and Quercetin in Combination Have Anticancer Activity in Colon Cancer Cells and Repress Oncogenic microRNA-27a

Stephen Safe, Nivedita Banerjee, S. Safe, 2013, Nutrition and cancer.

Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Stephen Safe, S. Safe, U. Jin, 2014, Molecular endocrinology.